文献速递性腺与生殖内分泌

多囊卵巢综合征

Polycystic ovary syndrome.
PubMed 文献 · Lancet Diabetes Endocrinol · 2022-08-04

多囊卵巢综合征(PCOS)影响5-18%的女性,是一种贯穿全生命周期的生殖、代谢和心理疾病。诊断推荐基于2003年鹿特丹标准,需符合高雄激素血症、月经不规律和卵巢多囊样形态三项中的两项;青少年需同时具备高雄激素血症和月经不规律,且不纳入卵巢形态。治疗包括生活方式优化和药物治疗,如二甲双胍、复方口服避孕药和抗雄激素药物。

要点

  • PCOS影响5-18%的女性,涉及生殖、代谢和心理多方面。
  • 诊断推荐2003年鹿特丹标准,需三项中两项;青少年不纳入卵巢形态。
  • 治疗包括生活方式优化和药物管理,如二甲双胍和复方口服避孕药。

核心结论

  • 本文综述了PCOS的病理生理、诊断和临床特征,并讨论了患者需求和国际循证指南的现状与转化。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • PCOS影响5-18%的女性,病因复杂,包括遗传和表观遗传易感性、下丘脑和卵巢功能障碍、雄激素暴露过多、胰岛素抵抗和肥胖相关机制。
  • 诊断推荐基于2003年鹿特丹标准,需符合高雄激素血症(临床或生化)、月经不规律和卵巢多囊样形态三项中的两项。
  • 青少年诊断需同时具备高雄激素血症和月经不规律,不纳入卵巢形态因特异性差。
  • 诊断标准产生四种表型,临床特征异质,表现通常始于童年并随青春期和成年演变。
  • 治疗包括生活方式优化(健康均衡饮食和规律运动)和药物管理(二甲双胍改善胰岛素抵抗和代谢特征,复方口服避孕药调节月经周期和高雄激素血症,必要时抗雄激素药物用于难治性高雄激素血症)。

关键数值与推荐

  • 诊断推荐基于2003年鹿特丹标准,需三项中两项。
  • 青少年诊断需同时具备高雄激素血症和月经不规律,不纳入卵巢形态。
  • 生活方式优化包括健康均衡饮食和规律运动。
  • 药物管理选项包括二甲双胍、复方口服避孕药和抗雄激素药物。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Polycystic ovary syndrome (PCOS) affects 5-18% of women, and is a reproductive, metabolic, and psychological condition with impacts across the lifespan. The cause is complex, and includes genetic and epigenetic susceptibility, hypothalamic and ovarian dysfunction, excess androgen exposure, insulin resistance, and adiposity-related mechanisms. Diagnosis is recommended based on the 2003 Rotterdam criteria and confirmed with two of three criteria: hyperandrogenism (clinical or biochemical), irregular cycles, and polycystic ovary morphology. In adolescents, both the criteria of hyperandrogenism and irregular cycles are needed, and ovarian morphology is not included due to poor specificity. The diagnostic criteria generates four phenotypes, and clinical features are heterogeneous, with manifestations typically arising in childhood and then evolving across adolescent and adult life. Treatment involves a combination of lifestyle alterations and medical management. Lifestyle optimisation includes a healthy balanced diet and regular exercise to prevent excess weight gain, limit PCOS complications and target weight reduction when needed. Medical management options include metformin to improve insulin resistance and metabolic features, combined oral contraceptive pill for menstrual cycle regulation and hyperandrogenism, and if needed, anti-androgens for refractory hyperandrogenism. In this Review, we provide an update on the pathophysiology, diagnosis, and clinical features of PCOS, and discuss the needs and priorities of those with PCOS, including lifestyle, and medical and infertility treatment. Further we discuss the status of international evidence-based guidelines (EBG) and translation, to support patient self management, healthcare provision, and to set research priorities.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022. PMID: 35934017. doi:10.1016/S2213-8587(22)00163-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。